Neuland Laboratories
Update in progressNEULANDLAB.NS (NSE)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
Neuland Laboratories Limited manufactures and markets active pharmaceutical ingredients (APIs) for customers in India, Europe, the United States, and globally. The company also offers custom manufacturing solutions and peptide synthesis services. Incorporated in 1984, Neuland is headquartered in Hyderabad, India.
Company score
- Sentiment
- 0.34
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.12
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.10
- Governance
- 0.14
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.10
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.22
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNSE (NSI)
- LocationIndia
- CEOMr. Davuluri Saharsh Rao
- Founded1984
- Employees2,183
- Websitewww.neulandlabs.com
Identifiers
- ISININE794A01010